4.84
전일 마감가:
$4.60
열려 있는:
$4.61
하루 거래량:
692.39K
Relative Volume:
0.79
시가총액:
$468.90M
수익:
-
순이익/손실:
$-238.77M
주가수익비율:
-0.1805
EPS:
-26.808
순현금흐름:
$-216.62M
1주 성능:
+1.89%
1개월 성능:
+46.22%
6개월 성능:
-6.38%
1년 성능:
-62.45%
Alumis Inc Stock (ALMS) Company Profile
명칭
Alumis Inc
전화
650-231-6625
주소
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
ALMS을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ALMS
Alumis Inc
|
4.84 | 500.47M | 0 | -238.77M | -216.62M | -26.81 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Alumis Inc Stock (ALMS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-25 | 개시 | Wells Fargo | Overweight |
2025-06-10 | 재개 | Guggenheim | Buy |
2025-01-30 | 개시 | Oppenheimer | Outperform |
2024-10-31 | 개시 | Robert W. Baird | Outperform |
2024-10-17 | 개시 | H.C. Wainwright | Buy |
2024-07-23 | 개시 | Cantor Fitzgerald | Overweight |
2024-07-23 | 개시 | Guggenheim | Buy |
2024-07-23 | 개시 | Leerink Partners | Outperform |
2024-07-23 | 개시 | Morgan Stanley | Overweight |
모두보기
Alumis Inc 주식(ALMS)의 최신 뉴스
Candlestick Signal Suggests Reversal in Alumis Inc.2025 Retail Activity & Entry Point Strategy Guides - beatles.ru
Analyzing Alumis Inc. with multi timeframe chartsDollar Strength & Entry and Exit Point Strategies - Newser
Alumis Inc. stock daily chart insightsJuly 2025 Decliners & Target Return Focused Picks - Newser
What high frequency data says about Alumis Inc.July 2025 Closing Moves & High Yield Stock Recommendations - Newser
Is Alumis Inc. meeting your algorithmic filter criteriaTrade Entry Report & AI Enhanced Market Trend Forecasts - Newser
Is Alumis Inc. stock a good hedge against inflation2025 Year in Review & Growth Oriented Trade Recommendations - Newser
Predicting Alumis Inc. trend using moving averagesCPI Data & Free Daily Entry Point Trade Alerts - Newser
How high can Alumis Inc. stock goEarnings Recap Report & Daily Profit Focused Screening - Newser
Real time social sentiment graph for Alumis Inc.2025 Fundamental Recap & Technical Buy Zone Confirmation - Newser
Will Alumis Inc. price bounce be sustainableRecession Risk & Verified Entry Point Detection - Newser
Smart tools for monitoring Alumis Inc.’s price actionJuly 2025 Selloffs & Risk Managed Investment Signals - Newser
Reversal indicators forming on Alumis Inc. stock2025 Biggest Moves & Safe Swing Trade Setups - Newser
Alumis Inc. Reports Q2 2025 Earnings and Strategic Advances - TipRanks
Why Alumis Inc. stock attracts strong analyst attention2025 Volume Leaders & Real-Time Stock Entry Alerts - Newser
Equities Analysts Set Expectations for Alumis Q3 Earnings - Defense World
Will breakout in Alumis Inc. lead to full recovery2025 Macro Impact & Low Risk Entry Point Tips - Newser
What makes Alumis Inc. stock price move sharplyQuarterly Portfolio Review & Advanced Swing Trade Entry Plans - Newser
Can momentum traders help lift Alumis Inc.Market Movement Recap & Stepwise Trade Signal Implementation - Newser
Is Alumis Inc. a stock for growth or value investorsJuly 2025 Momentum & Detailed Earnings Play Strategies - classian.co.kr
Morgan Stanley Lowers Alumis (NASDAQ:ALMS) Price Target to $22.00 - Defense World
Can machine learning forecast Alumis Inc. recoveryWeekly Investment Recap & Stock Timing and Entry Methods - Newser
Alumis Inc. Builds Base for Possible ReboundWeekly Risk Summary & Consistent Profit Trading Strategies - metal.it
Alumis Inc. Stock Support and Resistance Levels You Should KnowWeekly Risk Summary & Reliable Volume Spike Trade Alerts - Newser
Alumis Inc.: A Biopharma Bargain Amid Clinical Catalysts and Analyst Optimism - AInvest
Alumis Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - simplywall.st
Alumis Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - 富途牛牛
How Alumis Inc. stock performs during market volatilityPortfolio Value Report & Daily Stock Trend Reports - thegnnews.com
Relative strength of Alumis Inc. in sector analysisJuly 2025 Opening Moves & Entry and Exit Point Strategies - Newser
Alumis Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Alumis Inc. shares fall 1.36% intraday after reporting Q2 2025 financial results and merger with Acelyrin. - AInvest
Cantor Fitzgerald reiterates Overweight rating on Alumis stock amid post-merger decline - Investing.com
Alumis Inc.: Strong Buy Rating Backed by Promising Drug Candidate and Strategic Positioning - TipRanks
Alumis Misses Q2 Revenue as Costs Jump - AOL.com
Alumis Q2 Revenue Down 5% YoY, Cash to Fund Ops into 2027 - AInvest
Alumis reports Q2 revenue $2.67M, consensus $2.43M - TipRanks
Alumis Reports Second Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times
Alumis Hits Major Milestone in Psoriasis Drug Development, Strengthens Pipeline with $486M War Chest - Stock Titan
Alumis Inc. (NASDAQ:ALMS) Given Average Recommendation of “Buy” by Brokerages - Defense World
What momentum shifts mean for Alumis Inc.Free Entry Plan for Oversold Reversal Stocks - Newser
Is Alumis Inc. reversing from oversold territoryPredictive Short-Term Market Reversal Alerts - Newser
While institutions invested in Alumis Inc. (NASDAQ:ALMS) benefited from last week's 4.1% gain, individual investors stood to gain the most - uk.finance.yahoo.com
Alumis Inc.'s (NASDAQ:ALMS) market cap touched US$444m last week, benefiting both retail investors who own 38% as well as institutions - simplywall.st
Alumis Inc. (NASDAQ:ALMS) Stock Position Boosted by Bank of New York Mellon Corp - Defense World
Alumis Inc. Concludes 2025 Annual Stockholders Meeting - The Globe and Mail
How strong is Alumis Inc. company’s balance sheetMassive stock growth - Jammu Links News
What is the dividend policy of Alumis Inc. stockGet alerts on high-potential stock breakouts - Jammu Links News
Should I hold or sell Alumis Inc. stock in 2025Build a portfolio that outperforms consistently - Jammu Links News
When is Alumis Inc. stock expected to show significant growthBuild a winning portfolio with smart picks - Jammu Links News
What drives Alumis Inc. stock priceInvest confidently with real-time data analysis - Jammu Links News
How volatile is Alumis Inc. stock compared to the marketInvest in stocks with strong fundamentals - Jammu Links News
What are analysts’ price targets for Alumis Inc. in the next 12 monthsCapitalize on trading strategies that deliver - Jammu Links News
Alumis Inc (ALMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Alumis Inc 주식 (ALMS) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Tananbaum James B. | Director |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
Foresite Labs, LLC | 10% Owner |
May 02 '25 |
Buy |
4.62 |
25,000 |
115,500 |
4,227,670 |
Foresite Labs, LLC | 10% Owner |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
Foresite Capital Management VI | 10% Owner |
May 02 '25 |
Buy |
4.62 |
25,000 |
115,500 |
4,227,670 |
Foresite Capital Management VI | 10% Owner |
May 06 '25 |
Buy |
4.34 |
20,000 |
86,800 |
4,247,670 |
AKKARAJU SRINIVAS | Director |
May 05 '25 |
Buy |
4.67 |
160,370 |
749,676 |
3,586,788 |
AKKARAJU SRINIVAS | Director |
May 02 '25 |
Buy |
4.55 |
159,920 |
727,636 |
3,426,418 |
Colowick Alan | Director |
Apr 01 '25 |
Buy |
6.97 |
16,104 |
112,309 |
16,104 |
Colowick Alan | Director |
Apr 02 '25 |
Buy |
7.49 |
2,300 |
17,235 |
18,404 |
Babler Martin | President, CEO and Chairman |
Apr 01 '25 |
Buy |
6.44 |
15,650 |
100,733 |
106,454 |
자본화:
|
볼륨(24시간):